The article presents the results of the use of general magnetic therapy in the early postoperative period in patients with uterine adenomyosis in the early postoperative period after FUZ-ablation. The study involved 96 women who were divided into 2 groups: the main group — 48 patients who, in the early postoperative period after FUS-ablation, on the background of standard treatment, received a course of general magnetic therapy consisting of 10daily procedures and a control group — 48 patients received only standard treatment, including symmetrical and analgesic therapy. In the initial state, the patients had a violation of the hemostasis system, which was manifested in a significant increase in all studied parameters: the platelet platelet platelet activity index 1,27 times (р < 0,05); activated partial thrombin time — 1,23 times (р < 0,05), fibrinogen A — 1,57 times (р < 0,01), blood clotting time — 1,21 times (р < 0,05) and the accumulation of fibrin degradation products, as well as a moderate increase in FSH — by 1,38 times (р < 0,05) against the background of a decreased by 1,62 times (р < 0.05) estradiol content (for 5–7days of the menstrual cycle) adecrease in progesterone by 4,3 times (р < 0,05) and a moderate increase in LH by 1.39 times (р < 0,05) in blood serum and against the background of an increase in 1,8 times the level of cortisol (р < 0,05) for 20–22 days of the cycle. After the course of treatment, it was found that the use of general magnetic therapy in patients in the early postoperative period after FUS-ablation for adenomyosis contributes to the normalization of hemostasis system indicators and the elimination of hormonal imbalance.